latest news releases from the newsroom
Investor Relations Group
Celebrating Black History Month
LAMBERTVILLE, N.J., Feb. 3, 2006 (PRIMEZONE) -- In celebration of Black History Month, "Adaaye Afrique: Roots and Branches of African Art" will display traditional and contemporary African art at 13 North Union Street, Lambertville, N.J., from Tuesday, Feb. 7 through Sunday, Feb. 26. The exhibition will showcase works by Senegalese artist Ibou Ndoye, along with selections of traditional and tradition-based forms from a diverse range of African cultures. The event is intended to inspire awareness of and interest in the diverse and ever-evolving artistic traditions themselves, as well as the people and places that produce them.
Aduromed Industries, Inc.
Aduromed Corporation Completes $7.0 Million Equity Financing
BETHEL, Conn., Feb. 3, 2006 (PRIMEZONE) -- On January 23, 2006, Aduromed Corporation of Bethel, Connecticut, completed a $7,000,000 equity financing with Pequot Capital Management, Inc. of Westport, Connecticut, and Siar Capital of New York City, and its "reverse merger" with the public company General Devices, Inc. (OTCBB:GDVC).
Telenor Supports Exploration of Potential Strategic Alliances Between VimpelCom and Ukrainian Mobile Operators
FORNEBU, Norway and MOSCOW, Feb. 3, 2006 (PRIMEZONE) -- Telenor ASA today announced it would support cooperation - for example, a service provider agreement - between Russian mobile operator VimpelCom and Ukrainian mobile operators, including Kyivstar G.S.M. As a strong supporter of VimpelCom's expansion plans, Telenor also criticized Alfa-nominated Board members of VimpelCom for their failure to approve 2006 VimpelCom budgets for Russia, Kazakhstan, Tajikistan and Uzbekistan.
Novo Nordisk A/S
Novo Nordisk A/S: Director/PDMR Shareholding
BAGSVAERD, Denmark, Feb. 3, 2006 (PRIMEZONE) -- In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons as reported by those persons to Novo Nordisk.
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals to Present at The Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
NEW YORK, Feb. 3, 2006 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the Company, including the KRX-101 (sulodexide) Phase II data and the ongoing Phase III/IV clinical program, at The Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City. Mr. Weiss' presentation will take place on Tuesday, February 7, 2006 at 1:00 p.m. Eastern Time in Ballroom C of the Grand Hyatt New York Hotel. A live audio webcast of Mr. Weiss' presentation will be available at http://www.wsw.com/webcast/ml53/kerx/. An archived version of the webcast will be available following the conclusion of the live presentation.
ADVA Optical Networking
ADVA Optical Networking Completes Acquisition of Covaro Networks
MUNICH, Germany, Feb. 3, 2006 (PRIMEZONE) -- MARTINSRIED, MUNICH, Germany and MAHWAH, New Jersey, Feb. 3, 2006 -- ADVA Optical Networking today announced that the acquisition of all material assets in Covaro Networks Inc. was successfully completed. The total number of newly-issued ADVA non par value bearer shares for the acquisition of Covaro was 2,024,190.
MorphoSys Reports Preliminary Financial Results for 2005
MARTINSRIED, Germany, Feb. 3, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today reported preliminary unaudited financial results according to International Financial Reporting Standards (IFRS) accounting for the full year 2005. MorphoSys surpassed its financial guidance for 2005.